Literature DB >> 16627902

Paraneoplastic coma and acquired central alveolar hypoventilation as a manifestation of brainstem encephalitis in a patient with ANNA-1 antibody and small-cell lung cancer.

Kwan S Lee1, Michaela J Higgins, Bhavesh M Patel, Joel S Larson, Mohamed Y Rady.   

Abstract

INTRODUCTION: Paraneoplastic neurological disorders are a well recognized complication of malignancy.
METHODS: A case report to expand the currently described clinical manifestations of type 1 antineuronal antibody (ANNA-1)-associated paraneoplastic encephalomyelitis to include coma.
RESULTS: We present an unusual case of fluctuating coma and rapid fulminant progression to acute respiratory failure from central alveolar hypoventilation caused by ANNA-1 paraneoplastic encephalomyelitis associated with small-cell lung carcinoma. Paraneoplastic infiltration of the brainstem and cerebellum, including respiratory and arousal centers, was documented on autopsy.
CONCLUSIONS: Paraneoplastic encephalomyelitis should be considered as a possible cause of coma and central alveolar hypoventilation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627902     DOI: 10.1385/NCC:4:2:137

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  16 in total

1.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors:  F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

2.  Reversible limbic encephalitis caused by ovarian teratoma.

Authors:  K Nokura; H Yamamoto; Y Okawara; H Koga; H Osawa; K Sakai
Journal:  Acta Neurol Scand       Date:  1997-06       Impact factor: 3.209

Review 3.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

4.  Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients.

Authors:  J Dalmau; F Graus; M K Rosenblum; J B Posner
Journal:  Medicine (Baltimore)       Date:  1992-03       Impact factor: 1.889

5.  Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.

Authors:  M R Rosenfeld; J G Eichen; D F Wade; J B Posner; J Dalmau
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

6.  ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity.

Authors:  K H Chan; S Vernino; V A Lennon
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

7.  Noncirrhotic hepatoma presenting with paraneoplastic neurologic manifestations: two cases.

Authors:  S Norris; S Rajendiran; K Sheahan; S Murphy; D Royston; R Alyusuf; M Farrell; P A McCormick
Journal:  Am J Gastroenterol       Date:  1997-10       Impact factor: 10.864

8.  Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.

Authors:  Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

9.  Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.

Authors:  Sean J Pittock; Thomas J Kryzer; Vanda A Lennon
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

10.  Clinical analysis of anti-Ma2-associated encephalitis.

Authors:  Josep Dalmau; Francesc Graus; Alberto Villarejo; Jerome B Posner; Deborah Blumenthal; Brian Thiessen; Albert Saiz; Patricio Meneses; Myrna R Rosenfeld
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

View more
  3 in total

1.  Central hypoventilation as the presenting symptom in Hu associated paraneoplastic encephalomyelitis.

Authors:  Manuel J Gómez-Choco; Juan J Zarranz; Albert Saiz; María I Forcadas; Francesc Graus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-10       Impact factor: 10.154

Review 2.  Sleep Disturbances Associated with Neurological Autoimmunity.

Authors:  Michelle F Devine; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

3.  Patients with End-stage Interstitial Lung Disease may have More Problems with Dyspnea than End-stage Lung Cancer Patients.

Authors:  Ryo Matsunuma; Hazuki Takato; Yoshihiro Takeda; Satoshi Watanabe; Yuko Waseda; Shinya Murakami; Yukimitsu Kawaura; Kazuo Kasahara
Journal:  Indian J Palliat Care       Date:  2016 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.